ENTERA BIO LTD. Basic Shares Outstanding (Weighted Average)
ENTERA BIO LTD. (ENTX) reported Basic Shares Outstanding (Weighted Average) of 50.45 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-07
- ENTERA BIO LTD. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 50.45M shares, a 7.72% increase year-over-year.
- ENTERA BIO LTD. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 47.76M shares, a 10.10% increase year-over-year.
- ENTERA BIO LTD. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 47.28M shares, a 20.88% increase year-over-year.
- ENTERA BIO LTD. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 47.09M shares, a 25.09% increase year-over-year.
- ENTERA BIO LTD. weighted average number of shares outstanding, basic for fiscal 2025 was 46.19M shares, a 22.68% increase from fiscal 2024.
- ENTERA BIO LTD. weighted average number of shares outstanding, basic for fiscal 2024 was 37.65M shares, a 29.79% increase from fiscal 2023.
- ENTERA BIO LTD. weighted average number of shares outstanding, basic for fiscal 2023 was 29.01M shares, a 0.69% increase from fiscal 2022.
- ENTERA BIO LTD. weighted average number of shares outstanding, basic for fiscal 2022 was 28.81M shares, a 10.23% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 50.45M shares 10-Q · filed 2026-08-07 | 49.10M shares 10-Q · filed 2026-08-07 | 48.49M shares derived: average of 3 quarters · filed 2026-08-07 | 48.14M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | 47.76M shares 10-Q · filed 2026-05-08 | 47.52M shares derived: average of 2 quarters · filed 2026-05-08 | 47.37M shares derived: average of 3 quarters · filed 2026-05-08 | 47.24M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | 47.28M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 47.18M shares derived: average of 2 quarters · filed 2026-03-27 | 47.07M shares derived: average of 3 quarters · filed 2026-08-07 | 46.19M shares 10-K · filed 2026-03-27 |
| 2025-09-30 | 47.09M shares 10-Q · filed 2025-11-14 | 46.96M shares derived: average of 2 quarters · filed 2026-08-07 | 45.83M shares 10-Q · filed 2025-11-14 | 44.10M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | 46.84M shares 10-Q · filed 2026-08-07 | 45.15M shares 10-Q · filed 2026-08-07 | 43.11M shares derived: average of 3 quarters · filed 2026-08-07 | 41.74M shares derived: average of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | 43.38M shares 10-Q · filed 2026-05-08 | 41.24M shares derived: average of 2 quarters · filed 2026-05-08 | 40.04M shares derived: average of 3 quarters · filed 2026-05-08 | 39.31M shares derived: average of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | 39.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | 38.38M shares derived: average of 2 quarters · filed 2026-03-27 | 37.95M shares derived: average of 3 quarters · filed 2026-03-27 | 37.65M shares 10-K · filed 2026-03-27 |
| 2024-09-30 | 37.64M shares 10-Q · filed 2025-11-14 | 37.37M shares derived: average of 2 quarters · filed 2025-11-14 | 37.16M shares 10-Q · filed 2025-11-14 | 35.27M shares derived: average of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | 37.09M shares 10-Q · filed 2025-08-08 | 36.91M shares 10-Q · filed 2025-08-08 | 34.47M shares derived: average of 3 quarters · filed 2025-08-08 | 33.06M shares derived: average of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | 36.74M shares 10-Q · filed 2025-05-09 | 33.17M shares derived: average of 2 quarters · filed 2025-05-09 | 31.71M shares derived: average of 3 quarters · filed 2025-05-09 | 30.99M shares derived: average of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | 29.59M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | 29.20M shares derived: average of 2 quarters · filed 2025-03-28 | 29.07M shares derived: average of 3 quarters · filed 2025-03-28 | 29.01M shares 10-K · filed 2025-03-28 |
| 2023-09-30 | 28.81M shares 10-Q · filed 2024-11-08 | 28.81M shares derived: average of 2 quarters · filed 2024-11-08 | 28.81M shares 10-Q · filed 2024-11-08 | 28.81M shares derived: average of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | 28.81M shares 10-Q · filed 2024-08-09 | 28.81M shares 10-Q · filed 2024-08-09 | 28.81M shares derived: average of 3 quarters · filed 2024-08-09 | 28.81M shares derived: average of 4 quarters · filed 2024-08-09 |
| 2023-03-31 | 28.81M shares 10-Q · filed 2024-05-10 | 28.81M shares derived: average of 2 quarters · filed 2024-05-10 | 28.81M shares derived: average of 3 quarters · filed 2024-05-10 | 28.81M shares derived: average of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | 28.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | 28.81M shares derived: average of 2 quarters · filed 2024-03-08 | 28.81M shares derived: average of 3 quarters · filed 2024-03-08 | 28.81M shares 10-K · filed 2024-03-08 |
| 2022-09-30 | 28.81M shares 10-Q · filed 2023-11-14 | 28.81M shares derived: average of 2 quarters · filed 2023-11-14 | 28.81M shares 10-Q · filed 2023-11-14 | 28.84M shares derived: average of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | 28.81M shares 10-Q · filed 2023-08-11 | 28.81M shares 10-Q · filed 2023-08-11 | 28.85M shares derived: average of 3 quarters · filed 2023-08-11 | 28.80M shares derived: average of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | 28.80M shares 10-Q · filed 2023-05-05 | 28.86M shares derived: average of 2 quarters · filed 2023-05-05 | 28.80M shares derived: average of 3 quarters · filed 2023-05-05 | 27.78M shares derived: average of 4 quarters · filed 2023-05-05 |
| 2021-12-31 | 28.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | 28.80M shares derived: average of 2 quarters · filed 2023-03-31 | 27.44M shares derived: average of 3 quarters · filed 2023-03-31 | 26.13M shares 10-K · filed 2023-03-31 |
| 2021-09-30 | 28.68M shares 10-Q · filed 2022-11-10 | 26.70M shares derived: average of 2 quarters · filed 2022-11-10 | 25.20M shares 10-Q · filed 2022-11-10 | |
| 2021-06-30 | 24.72M shares 10-Q · filed 2022-08-11 | 23.38M shares 10-Q · filed 2022-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |